George Mulligan

About

George Mulligan, PhD, serves as Chief Scientific Officer at the MMRF. In this role, Dr. Mulligan leads the development, execution, and communication of the MMRF’s overall research strategy to drive clinically meaningful scientific advances for myeloma patients. Dr. Mulligan also contributes to all aspects of the MMRF and its subsidiary companies, the Multiple Myeloma Research Consortium (MMRC) and the Myeloma Investment Fund (MIF), to accelerate the development of next-generation therapies, drive research to deliver more precise and personalized treatment approaches, and empower patients with information and resources to extend their lives.

Source (opens in a new tab)